Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics.

Learn More

Search for an Alzheimer’s Treatment Goes On

Hopes were high for Axovant’s experimental drug, interpirdine, but results of a Phase 3 trial of  the potential Alzheimer’s treatment failed to meet its co-primary endpoints. What’s next?

 

Learn More

Meet us as the JP Morgan Healthcare Conference!

We’ll be attending the JP Morgan Healthcare conference in San Francisco in January 2018. If you will be there or in the Bay Area and would like to schedule a meeting, please let us know!

Contact Us

 

Orphans Should Live Alone

Read our recent article for In Vivo with advice for pharma interested in rare diseases.

 

Learn More

How Immuno-Oncology Is Turning Biomarker Development On Its Head

 

Our latest article in In Vivo covers the challenges in orchestrating a biomarker program in immuno-oncology.

 

Learn More

New Big Data Initiatives in Oncology

Read our take on the emerging field of ‘Real-time Oncology’ – the ability to constantly monitor changes in a patient’s disease and adjust treatment accordingly.

Learn More

About Bionest

We help clients navigate complex product development and commercialization issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments. Our deep content experience, combined with our collaborative and hands-on approach results in practical solutions that drive internal alignment at the corporate, portfolio, and brand levels.